Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hyperfine (HYPR)
NASDAQ:HYPR
Hyperfine (HYPR) Stock Price & Analysis
66 Followers
HYPR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.76 - $3.28
Previous Close$0.84
Volume50.72K
Average Volume (3M)93.04K
Market Cap
$65.79M
Enterprise Value-$14.62M
Total Cash (Recent Filing)$75.18M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.4
Beta0.64
Next Earnings
Aug 07, 2024EPS Estimate
-$0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding72,007,954
10 Day Avg. Volume117,418
30 Day Avg. Volume93,039
Standard Deviation0.25
R-Squared0.05
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.75
Price to Sales (P/S)4.34
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.33
Enterprise Value/Gross Profit-3.07
Enterprise Value/Ebitda0.44
Forecast
1Y Price Target
$1.27Price Target Upside39.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Hyperfine News
Bulls Say, Bears Say
Bulls Say
EarningsHYPR reported 1Q24 sales of $3.3 million, exceeding the market consensus.
Operational EfficiencyHYPR's focus on operational expenses showcases the company's commitment to financial discipline.
Product AdoptionThe integration of Swoop in the Alzheimer's treatment process is poised to drive widespread adoption of HYPR's technology.
Bears Say
Commercialization ChallengesHYPR remains in the early stages of commercialization and may face hurdles such as awareness, representative productivity, and expanding clinical indications.
Financial PerformanceGross margins were 38.5%, below the analyst's estimate of 46%.
Revenue ForecastGuidance for 2024 revenue was reiterated with expected lower average selling prices due to more overseas sales mix.
---
Ownership Overview
46.29% Insiders
6.65% Mutual Funds
14.28% Other Institutional Investors
32.79% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HYPR FAQ
What was Hyperfine’s price range in the past 12 months?
Hyperfine lowest stock price was $0.76 and its highest was $3.28 in the past 12 months.
What is Hyperfine’s market cap?
Currently, no data Available
When is Hyperfine’s upcoming earnings report date?
Hyperfine’s upcoming earnings report date is Aug 07, 2024 which is in 82 days.
How were Hyperfine’s earnings last quarter?
Hyperfine released its earnings results on May 13, 2024. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.147 by $0.007.
Is Hyperfine overvalued?
According to Wall Street analysts Hyperfine’s price is currently Undervalued.
Does Hyperfine pay dividends?
Hyperfine does not currently pay dividends.
What is Hyperfine’s EPS estimate?
Hyperfine’s EPS estimate is -$0.14.
How many shares outstanding does Hyperfine have?
Hyperfine has 56,952,667 shares outstanding.
What happened to Hyperfine’s price movement after its last earnings report?
Hyperfine reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.147. Following the earnings report the stock price went up 10%.
Which hedge fund is a major shareholder of Hyperfine?
Among the largest hedge funds holding Hyperfine’s share is HealthCor Management, L.P.. It holds Hyperfine’s shares valued at 4M.
---
Hyperfine Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.27 (39.01% Upside)
$1.27 (39.01% Upside)
Insider Transactions
Sold Shares
Worth $2.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.72%
12-Months-Change
Fundamentals
Return on Equity
-44.51%
Trailing 12-Months
Asset Growth
-30.02%
Trailing 12-Months
Company Description
Hyperfine
HealthCor Catalio Acquisition Corp is a blank check company.
---
HYPR Company Deck
---
HYPR Earnings Call
Q1 2024
0:00 / 0:00
---
HYPR Stock 12 Month Forecast
Average Price Target
$1.27
▲(39.01% Upside)
Technical Analysis
Best Analysts Covering HYPR
1 Year
1 Year Success Rate
1/6 ratings generated profit
1 Year Average Return
-9.03%
reiterated a buy rating 2 months ago
Copying Neil Chatterji's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -9.03% per trade.
---